Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

In this study 126 eyes in 63 patients with moderate bilateral myopia and astigmatism between -3 and -5 (SE difference between two eyes should not be more than 0.75 and the residual corneal thickness>350 μ ) were entered in the study. One eye went randomly under PRK with mitomycin C 0.02% in 15 min and then the other eye went under the operation without MMC. UCVA,BCVA, refractory error after the operation and the number of endothelial cells before and after the surgery would be compared in 6 months.

• Phase: Phase 1

Details

• Lead Sponsor: Shahid Beheshti University of Medical Sciences
• Treatments: Mitomycin; Mitomycins

Criteria

Inclusion Criteria:

• 19 < age < 60

• Refractory error stabled for at least one year

• No corneal pathology

• -3 < bilateral myopia and astigmatism < -5 with no difference more than 0.75 between 2 eyes

Exclusion criteria:

• Keratoconus

• Ectatic corneal disease

• Glaucoma

• Corneal dystrophy

• Lens changes affecting the visual acuity

• Anterior or posterior uveitis

• Corneal scar